Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
557.00    3.00 (0.54%)
Bid:
557.50
Ask:
558.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

22 Jun 2016 13:49

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the ‘Company’) has been informed that a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (‘Shares’) was made today to Executive Directors and Persons Discharging Managerial Responsibilities (‘PDMR’) as detailed in the table below:

Name Role Form of award (Option/ Conditional Award) Deferred Bonus1 Conditional Share Awards programme2
Rowan Adams PDMR Option 12,897 70,000
Javed Ahmed Executive Director Option 42,742 -
Joan Braca PDMR Conditional Award 9,369 90,000
Robert Gibber PDMR Option 18,524 80,000
Nick Hampton Executive Director Option 29,368 -
Rob Luijten PDMR Option 15,289 80,000
Gabriella Parisse PDMR Conditional Award 7,993 70,000
Pierre Schoumacher PDMR Conditional Award 11,755 70,000
James Stutelberg PDMR Conditional Award 12,842 90,000

1 Options and awards for the Deferred Bonus are awarded under the Tate & Lyle Group Bonus Plan (‘GBP’) in respect of the year ended 31 March 2016. No consideration is payable for the grant or exercise of the options or awards under the GBP. Further information on the operation of the GBP is provided in the Annual Report 2016.

2 Options and awards under the Conditional Share Award programme will only vest to the extent that certain Company-based financial performance criteria are satisfied over a performance period which runs from 1 April 2016 to 31 March 2017. No consideration is payable for the grant or exercise of the options or awards. Options and awards will be subject to a 12-month deferral period and continued employment to 31 March 2018.

All the above transactions took place in London.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FCA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

22 June 2016

View source version on businesswire.com: http://www.businesswire.com/news/home/20160622005771/en/

Copyright Business Wire 2016

Date   Source Headline
24th Jun 20261:36 pmRNSForm 8.3 - Tate & Lyle plc Replacement
24th Jun 202611:54 amRNSForm 8.3 - Tate and Lyle PLC
24th Jun 202611:35 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
24th Jun 202611:24 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle plc
24th Jun 202611:23 amRNSForm 8.5 (EPT/RI) - Tate & Lyle plc
24th Jun 202611:10 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
24th Jun 202611:04 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
24th Jun 202610:25 amRNSForm 8.3 Tate & Lyle Plc
24th Jun 20269:08 amRNSForm 8.5 (EPT/RI)
23rd Jun 20265:57 pmRNSForm 8.3 TATE & LYLE PLC
23rd Jun 20265:47 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle Amend
23rd Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
23rd Jun 20263:12 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Public dealing disclosure
23rd Jun 20262:57 pmRNSForm 8.3 - Tate & Lyle Plc
23rd Jun 20262:46 pmRNSForm 8.3 - Tate & Lyle plc
23rd Jun 20262:45 pmRNSForm 8.5 (EPT/RI)- Amend- Tate & Lyle PLC
23rd Jun 20261:52 pmRNSForm 8.3 - Tate & Lyle plc
23rd Jun 202612:04 pmRNSForm 8.3 Tate & Lyle
23rd Jun 202611:43 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
23rd Jun 202611:36 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
23rd Jun 202611:34 amRNSForm 8.5 (EPT/RI)- Tate & Lyle plc
23rd Jun 202611:32 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
23rd Jun 202611:30 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
23rd Jun 202611:29 amRNSForm 8.5 (EPT/RI) - Tate & Lyle plc
23rd Jun 202610:47 amRNSForm 8.3 Tate & Lyle Plc
23rd Jun 202610:04 amRNSForm 8.5 (EPT/RI) - Tate & Lyle plc
23rd Jun 20269:55 amRNSForm 8.5 (EPT/RI) - Amendment TATE & LYLE PLC
22nd Jun 20265:08 pmRNSForm 8.3 Tate & Lyle
22nd Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
22nd Jun 20263:08 pmRNSForm 8.3 - Tate & Lyle Plc
22nd Jun 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
22nd Jun 20262:59 pmRNSForm 8.3 - Tate & Lyle plc
22nd Jun 20262:44 pmRNSForm 8.3 Tate & Lyle Plc
22nd Jun 20262:34 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
22nd Jun 20261:56 pmRNSForm 8.3 Tate & Lyle Plc
22nd Jun 20261:56 pmRNSForm 8.3 - Tate & Lyle plc
22nd Jun 20261:02 pmRNSForm 8.3 TATE & LYLE PLC
22nd Jun 202612:51 pmRNSForm 8.3 - Tate & Lyle plc
22nd Jun 202612:41 pmRNSForm 8.3 - Tate&Lyle
22nd Jun 202612:19 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Public dealing disclosure
22nd Jun 202611:54 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
22nd Jun 202611:50 amRNSForm 8.5 - TATE & LYLE PLC
22nd Jun 202611:46 amRNSForm 8.5 (EPT/NON-RI)- Tate & Lyle plc
22nd Jun 202611:38 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
22nd Jun 202611:24 amRNSForm 8.5 (EPT/RI) - Tate & Lyle plc
22nd Jun 202611:17 amRNSForm 8.3 - Tate & Lyle plc
22nd Jun 202610:56 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
22nd Jun 20269:58 amRNSForm 8.3 Tate & Lyle Plc
22nd Jun 20269:12 amRNSForm 8.5 (EPT/RI)
22nd Jun 20268:38 amRNSForm 8.3 Tate & Lyle 11 06 2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.